Our clinically proven OvuSense platform helps screen for common health issues for which 50% of women currently go undiagnosed, and monitors the 70% of drugs that are affected by timing of dose in the reproductive cycle. OvuSense is a class II medical device with 11 clinical publications and 10 granted patents, providing unique insights through our cycle flag and 99% accurate cycle tracking algorithms.